AFP and hepatocellular carcinoma: The authors claim that they chose samples with a high AFP level for analysis, and it is uncertain whether the differences observed in the AFP’s glycan composition isolated either from HCC or from NSCGT patients would be the same/similar if low AFP level samples were included in the studies.